These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3797435)

  • 21. Assessing occupational hazards to reproduction: uses of existing data sets.
    Erickson JD
    Prog Clin Biol Res; 1984; 160():99-107. PubMed ID: 6548031
    [No Abstract]   [Full Text] [Related]  

  • 22. What is a human teratogen: clinical and epidemiological criteria.
    Bertollini R; Pagano M; Mastroiacovo P
    Ann Ist Super Sanita; 1993; 29(1):97-104. PubMed ID: 8129277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of organic solvents on the child-bearing function of women painters (an epidemiological hygiene study].
    Tikhonova GI; Lebedeva NV; Fedorova BV
    Med Tr Prom Ekol; 1997; (3):20-4. PubMed ID: 9162463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Birth defect surveillance in the search for and evaluation of possible human teratogens.
    Oakley GP
    J Environ Pathol Toxicol; 1978; 2(1):211-6. PubMed ID: 722223
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the association between birth defects and exposure to ambient vinyl chloride.
    Thériault G; Iturra H; Gingras S
    Teratology; 1983 Jun; 27(3):359-70. PubMed ID: 6879459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting prenatal and perinatal infections. The shortcomings of epidemiological studies: an example from Finland.
    Granroth G
    EURO Rep Stud; 1985; (93):96-103. PubMed ID: 3870833
    [No Abstract]   [Full Text] [Related]  

  • 27. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999.
    Stone KM; Reiff-Eldridge R; White AD; Cordero JF; Brown Z; Alexander ER; Andrews EB
    Birth Defects Res A Clin Mol Teratol; 2004 Apr; 70(4):201-7. PubMed ID: 15108247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital defects and environmental factors during pregnancy: nationwide surveillance.
    Holmberg PC
    Prog Clin Biol Res; 1985; 163B():287-9. PubMed ID: 3983153
    [No Abstract]   [Full Text] [Related]  

  • 29. [Epidemiological methods in teratology].
    Saxén L
    Proc Finn Dent Soc; 1980; 76(5-6):237-44. PubMed ID: 7019901
    [No Abstract]   [Full Text] [Related]  

  • 30. Congenital anomalies in relation to the use of doxylamine/dicyclomine and other antenatal factors: an ongoing prospective study.
    Gibson GT; Colley DP; McMichael AJ; Hartshorne JM
    Med J Aust; 1981 Apr; 1(8):410-4. PubMed ID: 7254087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement.
    Prater MR; Zimmerman KL; Ward DL; Holladay SD
    Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):862-9. PubMed ID: 15526292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy outcome following gestational exposure to organic solvents: a response.
    Brent RL; Chambers CD; Chernoff GF; Jones KL; Miller RK
    Teratology; 1999 Dec; 60(6):328-31. PubMed ID: 10590391
    [No Abstract]   [Full Text] [Related]  

  • 33. Cocaine during pregnancy: a critical review of the literature.
    Offidani C; Pomini F; Caruso A; Ferrazzani S; Chiarotti M; Fiori A
    Minerva Ginecol; 1995 Sep; 47(9):381-90. PubMed ID: 8545039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiologic approaches to reproductive hazards of the workplace.
    Sever LE
    Birth Defects Orig Artic Ser; 1982; 18(3 Pt A):33-8. PubMed ID: 7126795
    [No Abstract]   [Full Text] [Related]  

  • 35. Endpoints of reproductive dysfunction in an experimental epidemiological model: self-poisoned pregnant women.
    Czeizel A
    Dev Toxicol Environ Sci; 1986; 12():49-61. PubMed ID: 3829960
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dysmelia from the view-point of the obstetrician].
    von Massenbach W; Severin G
    Wien Med Wochenschr; 1967 Apr; 117(15):397-9. PubMed ID: 5593732
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiology of malformations: inspiration and perspiration.
    Smithells RW
    Teratology; 1974 Dec; 10(3):217-20. PubMed ID: 4456667
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of teratogenic risk: the contribution of abnormalities registries].
    De Wals P
    Rev Epidemiol Sante Publique; 1994; 42(5):392-8. PubMed ID: 7972998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance: symptoms, exposure, and trust.
    Stein ZA
    Prog Clin Biol Res; 1984; 160():131-8. PubMed ID: 6473469
    [No Abstract]   [Full Text] [Related]  

  • 40. Embryotoxicity: a challenge to clinical pharmacology.
    Brendel K; Duhamel RC
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S14-8. PubMed ID: 3842687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.